Original Research

Compare the Mean Blood Loss during a Term Caesarean Delivery in Primigravidas using Sublingual Misoprostol with an Intravenous Oxytocin Infusion

Maria Maqsood1
Lady Aitchison Hospital, Lahore
Shumaila Maqsood1
Lady Aitchison Hospital, Lahore
Kiran Nasir2
DHQ Hospital Mianwali
Hina Zafar1
Lady Aitchison Hospital, Lahore
Furqan Saeed3
Mayo Hospital Lahore
Iqra Waheed4
Biostatistician

✉ Correspondence: Maria Maqsood Email: docmaria0777@gmail.com

DOI https://doi.org/10.70302/jpsim.v3i4.2263
Volume: 3, Issue 4 Pages: 324–327 Published: 18 Dec 2022
Received: 23 Jul 2022 Accepted: 27 Sep 2022 Published Online: 18 Dec 2022

Abstract

Objective

The objective was to compare the mean1blood loss using sublingual misoprostol and intravenous oxytocin infusion in primigravidas undergoing caesarean section at term.

Methods

This Randomized Controlled Trial was done on 200 pregnant females who were later on randomly divided into two equal groups. The caesarean sections were performed via the transperitoneal approach. Within 2 hours, blood loss was noted. Data was entered & analyzed on SPSS V 21.

Results

The mean1age was 26.29±5.32 years. The mean blood loss was 169.47±35.80ml. The significant difference between the groups with mean blood loss of the1patients i.e. p-value = 0.000.

Conclusion

The use of sublingual misoprostol for management of blood loss is more effective than oxytocin in primigravida undergoing caesarean delivery

Keywords
Postpartum hemorrhage Blood Loss Misoprostol Oxytocin Caesarean Delivery

How to Cite This Article

Maqsood M, Maqsood S, Nasir K, Zafar H, Saeed F, Waheed I. Compare the Mean Blood Loss during a Term Caesarean Delivery in Primigravidas using Sublingual Misoprostol with an Intravenous Oxytocin Infusion. J Pak Soc Intern Med. 2022;3(4):324–327. doi:10.70302/jpsim.v3i4.2263

⭳ Download PDF

Conflict of Interest

All authors declare no competing interests.

Disclosed in accordance with ICMJE and COPE guidelines.

Funding

No specific funding was received for this research.

Funder information follows the Crossref Funder Registry standard.

References

  1. . Kolin DA, Shakur-Still H, Bello A, Chaudhri R, Bates I, Roberts I. Risk factors for blood transfusion in traumatic and postpartum hemorrhage patients: Analysis of the CRASH-2 and WOMAN trials. Plos one. 2020;15(6):e0233274.
  2. Shahbazi Sighaldeh S, Nazari A, Maasoumi R, Kazemnejad A, Mazari Z. Prevalence, related factors and maternal outcomes of primary postpartum haemorrhage in governmental hospitals in Kabul-Afghanistan. BMC Preg Childb. 2020;20(1):1-9.
  3. Snelgrove JW. Postpartum haemorrhage in the developing world a review of clinical management strategies. Mcgill J Med. 2009;12(2):61.
  4. Bahadur A, Khoiwal K, Bhattacharya N, Chaturvedi J, Kumari R. The effect of intrauterine misoprostol on blood loss during caesarean section. J Obstet Gynaecol. 2019;39(6):753-6.
  5. Janjua M, Imran M. A comparison of the effectiveness of sublingual misoprostol versus intravenous oxytocin infusion in reducing blood loss in first two hours at caesarean section. Pak Postgrad Med J. 2020;31(03):132-7.
  6. Afkham MS, Hashemnejad M, Saeieh SE, Ataei M, Valizadeh R. Prophylactic effect of rectal and sublingual misoprostol on postpartum hemorrhage in mothers with preeclampsia following cesarean section surgery; a double-blind randomised controlled trial. Ann Med Surg. 2022; doi: 10.1016/j.amsu.2022.104175. doi:10.1016/j.amsu.2022.104175
  7. Sel G. Postpartum Bleeding. Practical Guide to Oral Exams in Obstetrics and Gynecology: Springer; 2020. P. 171-5.
  8. Awoleke JO, Adeyanju BT, Adeniyi A, Aduloju OP, Olofinbiyi BA. Randomised Controlled Trial of Sublingual and Rectal Misoprostol in the Prevention of Primary Postpartum Haemorrhage in a Resource-Limited Community. J Obstet Gynecol India. 2020;70(6):462-70.
  9. Munawar A, Saeed A, Rehman A. Effect of rectal misoprostol and intravenous ergometrine in patients of postpartum hemorrhage in caesarean section delivery. JSZMC.2018;9(3):1487-89.
  10. Eftekhari N, Doroodian M, Lashkarizadeh R. The effect of sublingual misoprostol versus intravenous oxytocin in reducing bleeding after caesarean section. J Obstet Gynaecol. 2009;29(7):633-6.
  11. Sallam HF, Shady NW. Adjunctive sublingual misoprostol for secondary prevention of post-partum hemorrhage during cesarean delivery: double blind placebo randomized controlled trial. Int J Repro Contra Obstet Gynecol. 2018;7(2):496.
  12. Othman ER, Fayez MF, Abd El Aal DEM, Mohamed HSE-D, Abbas AM, Ali MK. Sublingual misoprostol versus intravenous oxytocin in reducing bleeding during and after cesarean delivery: a randomized clinical trial. Tai J Obstet Gynecol. 2016;55(6):791-5.
  13. Abdelaleem AA, Abdelaleem NA, Abbas AM. Intrauterine Misoprostol versus intravenous Oxytocin infusion during cesarean delivery to reduce intraoperative and postoperative blood loss: a randomised clinical trial. Int J Repro Contra Obstet Gynecol. 2019;8(4):1663.
  14. Baig FS, Ali F, Shahid M, Malik A. Comparison of rectally administered misoprostol and oxytocin infusion for management of 3rd stage of labour in 2nd trimester pregnancy loss. Pak Postgrad Med J. 2017;28(2):70-4.
  15. Eftekhari N, Doroodian M, Lashkarizadeh R. The effect of sublingual misoprostol versus intravenous oxytocin in reducing bleeding after caesarean section. J Obstet Gynaecol. 2009;29(7):633-6.
  16. Anita MS, Rajoria L, Mehta S. A randomised control study: To evaluate the effect of oxytocin plus misoprostol versus oxytocin or misoprostol alone in reducing blood loss at cesarean section. Int J Clin Obstet Gynaecol. 2018; 2(2): 1-3
  17. Rasri W. Intrauterine misoprostol plus intravenous oxytocin for reduction of blood loss in cesarean delivery. Thai Journal of Obstetrics and Gynaecology. 2018:237-45.
  18. Ahmed AO. A comparison of combined rectal misoprostol and oxytocin with oxytocin alone in the control of blood loss during elective caesarean section: a randomised controlled trial. Faculty of obstetrics and gynaecology. Dissertation. 2018.
  19. Abdullah NS, Homdy BT. Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section. Dissertation. 2019.

Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.

CC BY CC BY 4.0 This article is published under the Creative Commons Attribution 4.0 International License. May be shared and adapted with attribution. © 2022 Journal of Pakistan Society of Internal Medicine.
📃 In This Issue View All
Original Article Serum Ferritin as a Prognostic Marker in COVID-19 Severity: A Hospital-Based Study Rehman N, Sheikh I, Javed K Original Article Neonatal Sepsis: Bacteriological Profile and Antibiogram in a Tertiary Care Hospital Iqbal M, Rashid T Review Article Thyroid Disorders in Pregnancy: Clinical Implications and Management Strategies Baig BI, Usman A Original Article Impact of Diabetes Mellitus on Post-Operative Wound Healing in General Surgery Siddiqui FA, Noor M, Akhtar W Review Article Statin Therapy in Non-Alcoholic Fatty Liver Disease: A Systematic Review Nawaz F, Cheema HA, Mehmood Y
👥 More by These Authors
Original Article Outcomes of Laparoscopic Cholecystectomy in Acute Cholecystitis: A Retrospective Analysis Raza SH, Butt N, Qureshi AM Review Article Antibiotic Resistance Patterns in Community-Acquired Pneumonia: Emerging Trends Hussain I, Farooq Z Original Article Prevalence of Hypertension Among Urban Adults in Pakistan: A Cross-Sectional Study Khan TM, Ahmed S, Malik RA Original Article Cervical Cancer Screening Awareness Among Rural Women in Punjab Bibi S, Anjum R, Hassan F
🔗 Related Articles By Keywords
Review Article Thyroid Disorders in Pregnancy: Clinical Implications and Management Strategies Baig BI, Usman A Original Article Impact of Diabetes Mellitus on Post-Operative Wound Healing in General Surgery Siddiqui FA, Noor M, Akhtar W Review Article Statin Therapy in Non-Alcoholic Fatty Liver Disease: A Systematic Review Nawaz F, Cheema HA, Mehmood Y Original Article Comparison of Ultrasound-Guided versus Landmark-Based Central Venous Catheter Insertion Zafar S, Gillani SA